|
⚲
|
| Keyboard |
| GBS Venture Partners Pty Ltd
✚
|
|
|---|---|
| CIK # | 0001542845 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001542845] | |
| 4 | [0001542845] | |
| SC 13D | [0001542845] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| GBS Venture Partners PTY Ltd | Viveve Medical Inc | [2014-10-03] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Viveve Medical Inc | |
| GBS BioVentures III A/C | |
| GBS Venture Partners Pty Ltd | |
| Humanigen Inc | |
| Genesis Fund | |
| GBS BioVentures II A/C | |
| Nuwellis Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Viveve Medical Inc PLCSD
Common Stock
|
2014-09-23 | Buy | 947,872 | $0.53 | 502,372 |
|
Viveve Medical Inc PLCSD
Common Stock
|
2014-09-23 | Buy | 947,872 | $0.53 | 502,372 |
|
Humanigen Inc KBIO
Series B-2 Preferred Stock · derivative
|
2013-02-05 | Conversion | 487,469 | $0.00 | |
|
Humanigen Inc KBIO
Series D Preferred Stock · derivative
|
2013-02-05 | Conversion | 215,985 | $0.00 | |
|
Humanigen Inc KBIO
Series C Preferred Stock · derivative
|
2013-02-05 | Conversion | 84,406 | $0.00 | |
|
Humanigen Inc KBIO
Common Stock
|
2013-02-05 | Conversion | 825,613 | ||
|
Humanigen Inc KBIO
Common Stock
|
2013-01-31 | Buy | 25,000 | $8.00 | 200,000 |